go back

Ranibizumab (Susvimo) Sustained-Release Implant

Alabama rates for HCPCS C9093

Injection, ranibizumab, via sustained release intravitreal implant (Susvimo), 0.1 mg

Rates data updated July 2026.

Professionalmedian $81 · 10th–90th $79$1150%50%10th90th$81$100.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$79.43
Median
$81.28
Typical High
$114.82